Who Paid My Doc
Healey Platform Trial
ClinicalTrials.gov NCT04436510
Research payments
$852,320
Through program year 2022, $852,320 in research payments was reported against Healey Platform Trial, across 208 payments, paid by Biohaven Pharmaceutical Holding Company Ltd..
- Paid by
- Biohaven Pharmaceutical Holding Company Ltd.
- ClinicalTrials.gov
- NCT04436510
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $852,320 | 208 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Nicholas Olney Portland, OR Named on 8 payments
- Daragh Heitzman Dallas, TX Named on 8 payments
- Jinsy Andrews New York, NY Named on 8 payments
- Nicholas Maragakis Baltimore, MD Named on 7 payments
- Ximena Arcila Londono Detroit, MI Named on 7 payments
- Michael Weiss Seattle, WA Named on 7 payments
- Omar Jawdat Kansas City, KS Named on 7 payments
- Jonathan Katz San Francisco, CA Named on 6 payments
- Kourosh Rezania Chicago, IL Named on 6 payments
- Matthew Elliott Charlottesville, VA Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.